DL-Phenylalanine

(±)-3-Phenyl-2-aminopropanoic acid (±)-Phenylalanine (±)-β-Phenyl-α-alanine (2R)-2-azaniumyl-3-phenyl-propanoate 2-Amino-3-phenylpropanoic acid 2-Amino-3-phenylpropionic acid, dl- 2-Azaniumyl-3-phenylpropanoate Alanine, phenyl-, DL- Alanine, phenyl-, DL- (8CI) Alanine, β-phenyl- alpha-Aminohydrocinnamic acid, dl- DL-2-Amino-3-phenylpropanoic acid DL-2-Amino-3-phenylpropionic acid DL-3-Phenylalanine DL-alpha-Amino-beta-phenylpropionic acid DL-beta-Phenyl-alpha-alanine DLPA DL-α-Amino-β-phenylpropionic acid DL-β-Phenyl-α-alanine H-DL-Phe-OH NSC 9959 Phenylalanine DL-form

SRP: Criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.
SRP: At the time of review, regulatory criteria for small quantity disposal are subject to significant revision, however, household quantities of waste pharmaceuticals may be managed as follows: Mix with wet cat litter or coffee grounds, double bag in plastic, discard in trash.
SRP: Expired or waste pharmaceuticals shall carefully take into consideration applicable DEA, EPA, and FDA regulations. It is not appropriate to dispose by flushing the pharmaceutical down the toilet or discarding to trash. If possible return the pharmaceutical to the manufacturer for proper disposal being careful to properly label and securely package the material. Alternatively, the waste pharmaceutical shall be labeled, securely packaged and transported by a state licensed medical waste contractor to dispose by burial in a licensed hazardous or toxic waste landfill or incinerator.